Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
What are Viruses?00:50

What are Viruses?

129.3K
Overview
129.3K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

959
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
959
Retroviruses02:33

Retroviruses

15.3K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regenerative Approaches to Enhance the Skin Microenvironment and Boost Aesthetic Efficacy: A Narrative Review.

International journal of molecular sciences·2026
Same author

Parkinson's Disease: From Metabolism to Genetics-A Comprehensive Review.

Current issues in molecular biology·2026
Same author

AI-Enhanced Transcriptomic Discovery of Druggable Targets and Repurposed Therapies for Huntington's Disease.

Brain sciences·2025
Same author

Comprehensive RNA-Seq Analysis of Human Osteoclast Function in Response to <i>Bothrops moojeni</i> Venom Fractions: Pathways of Bone Resorption and Cytoskeletal Disruption.

Toxins·2025
Same author

Preclinical In Vitro Evaluation of Extracellular Vesicles from Human Dental Pulp Stem Cells for the Safe and Selective Modulation of Anaplastic Thyroid Carcinoma.

International journal of molecular sciences·2025
Same author

From Brain to Blood: Uncovering Potential Therapeutical Targets and Biomarkers for Huntington's Disease Using an Integrative RNA-Seq Analytical Platform (BDASeq<sup>®</sup>).

Cells·2025

Related Experiment Video

Updated: Mar 7, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K

Papillomaviruses: a systematic review.

Rodrigo Pinheiro Araldi1,2, Suely Muro Reis Assaf1, Rodrigo Franco de Carvalho1

  • 1Laboratório de Genética, Instituto Butantan, São Paulo, SP, Brazil.

Genetics and Molecular Biology
|February 18, 2017
PubMed
Summary

Bovine papillomaviruses (BPV) are linked to cancer and herd health issues. Research using cattle as a model may lead to new vaccines for both BPV and human papillomavirus (HPV).

More Related Videos

Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
07:26

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes

Published on: February 22, 2012

19.8K

Related Experiment Videos

Last Updated: Mar 7, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K
Use of Interferon-&#947; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
07:26

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes

Published on: February 22, 2012

19.8K

Area of Science:

  • Virology
  • Oncology
  • Veterinary Medicine

Background:

  • Papillomaviruses are a group of viruses strongly associated with cancer development and prevalent across vertebrate species.
  • Bovine papillomaviruses (BPV) cause significant health and economic problems in cattle herds worldwide.
  • Human papillomavirus (HPV) is the primary cause of cervical cancer, a major global health concern.

Purpose of the Study:

  • To review studies utilizing bovines as a model for papillomavirus research.
  • To explore strategies for combating the clinical effects of BPV in livestock.
  • To assess the potential of BPV research models for developing human papillomavirus (HPV) interventions.

Main Methods:

  • Literature review of experimental reports on papillomaviruses in bovine models.
  • Analysis of data related to the development of prophylactic and therapeutic strategies.
  • Focus on recombinant DNA technology for vaccine development.

Main Results:

  • Bovine models offer valuable insights into papillomavirus pathogenesis and infection.
  • Recombinant DNA-based vaccines show promise for both prevention and treatment of BPV-related conditions.
  • The findings highlight the translational potential of bovine papillomavirus research for human applications.

Conclusions:

  • Bovine papillomavirus research provides a relevant model for understanding papillomavirus infections.
  • Developing vaccines using recombinant DNA technology is a viable strategy for BPV.
  • These strategies may serve as a foundation for novel approaches against human papillomavirus (HPV).